Mumbai, India

Hitesh Mistry


Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014-2021

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Hitesh Mistry: Innovator in Pharmaceutical Compounds

Introduction

Hitesh Mistry is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. With a total of four patents to his name, Mistry's work is recognized for its potential impact on medical treatments.

Latest Patents

Mistry's latest patents include innovative compounds such as ROR-gamma modulators and fused triterpene compounds. The ROR-gamma modulators patent relates to a compound of formula I, or its isotopic forms, stereoisomers, tautomers, and various derivatives. This invention also encompasses pharmaceutical compositions that utilize these compounds for treating diseases mediated by ROR-gamma. The fused triterpene compounds patent discloses compounds that serve as modulators for retinoid-related orphan receptors gamma and interleukin-17 inhibitors. These compounds are designed for use in treating diseases associated with these pathways.

Career Highlights

Throughout his career, Hitesh Mistry has worked with prominent organizations such as Piramal Enterprises Limited and Purdue Research Foundation. His experience in these companies has allowed him to develop and refine his innovative ideas in pharmaceutical research.

Collaborations

Mistry has collaborated with several professionals in his field, including Rajiv Sharma and Namdev Narayan Borhade. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Hitesh Mistry is a distinguished inventor whose work in pharmaceutical compounds has the potential to influence medical treatments significantly. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…